QUANTERIX CORP

QTRX · NASDAQ

Updated at 2026-10-14 09:13:45

$3.15-0.31%
Today's High
$3.33
Today’s Low
$3.11
QUANTERIX CORP (QTRX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$3.28
Previous Close
$3.16
Volume
562.78K
Market Cap
$149.44M
P/E Ratio
--
EPS
$-2.63

Previous Day Range

$3.07$3.35

52-Week Range

$2.15$8.77

Company Overview

Sector
HEALTHCARE
Industry
Life Sciences Tools & Services
Sub-industry
MEDICAL DEVICES
Headquarters
BUILDING 1, BILLERICA, MA, UNITED STATES, 01821
Country
US
Listing Date
2017-12-07
Fiscal Year End
December
Shares Outstanding
47.11M
CIK
0001503274

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$32.9M

2026-03-31

$36.41M

2025-12-31

$43.85M

2025-09-30

$40.15M

Operating Expenses

2026-06-30

$62.1M

2026-03-31

$37.09M

2025-12-31

$43.82M

2025-09-30

$54.44M

Net Income

2026-06-30

-$48.93M

2026-03-31

-$17.54M

2025-12-31

-$23.11M

2025-09-30

-$33.51M

Net Profit Margin

2026-06-30

-148.7%

2026-03-31

-48.16%

2025-12-31

-52.71%

2025-09-30

-83.47%

Earnings Per Share

2026-06-30

$-0.45

2026-03-31

$0.16

2025-12-31

$-0.47

2025-09-30

$-0.73

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$42.05M

2026-03-31

-$11.14M

2025-12-31

-$15.52M

2025-09-30

-$29.35M

Effective Tax Rate

2026-06-30

0.11%

2026-03-31

0.03%

2025-12-31

-1.51%

2025-09-30

6.88%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.